Cover Image
市場調查報告書

傳統血糖值計的全球市場:醫療設備的開發平台評估

Traditional Glucose Meters - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 365827
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
傳統血糖值計的全球市場:醫療設備的開發平台評估 Traditional Glucose Meters - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年08月01日 內容資訊: 英文 68 Pages
簡介

本報告提供全球傳統的血糖值計 (葡萄糖測量設備) 市場上,的主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 傳統血糖值計概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 傳統血糖值計的企業:各臨床實驗階段的開發中產品
  • 傳統血糖值計:各臨床實驗階段的開發中產品

第5章 傳統血糖值計市場:企業、產品概要

  • 4a Medicom GmbH
    • 開發中產品及進行中的臨床實驗概要
  • Ascensia Diabetes Care Holdings AG
  • Biopeak Corporation
  • BlueVine Graphene Industries, Inc.
  • Elte Sensoric GmbH
  • Glucosat
  • GlucoStats System Pte Ltd.
  • Grove Instruments Inc. (Inactive)
  • IntelliDx Inc
  • LabStyle Innovations Corp.
  • LifeScan, Inc.
  • LighTouch Medical, Inc.
  • Massachusetts Institute of Technology
  • NIR Diagnostics Inc. (Inactive)
  • OrSense Ltd.
  • Pepex Biomedical, Inc.
  • RSP Systems A/S
  • Sensys Medical, Inc.
  • Sentec Pte Ltd
  • Socrates Health Solutions, Inc.
  • Spire Corporation
  • TecMed, Inc.
  • University of Central Florida
  • University of Florida
  • Worcester Polytechnic Institute

第6章 傳統血糖值計市場:目前的趨勢 (共25件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0215EPD

GlobalData's Medical Devices sector report, "Traditional Glucose Meters - Medical Devices Pipeline Assessment, 2016" provides an overview of Traditional Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Traditional Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Traditional Glucose Meters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Traditional Glucose Meters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Traditional Glucose Meters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Traditional Glucose Meters Overview

3. Products under Development

  • 3.1. Traditional Glucose Meters - Pipeline Products by Stage of Development
  • 3.2. Traditional Glucose Meters - Pipeline Products by Territory
  • 3.3. Traditional Glucose Meters - Pipeline Products by Regulatory Path
  • 3.4. Traditional Glucose Meters - Pipeline Products by Estimated Approval Date
  • 3.5. Traditional Glucose Meters - Ongoing Clinical Trials

4. Traditional Glucose Meters - Pipeline Products under Development by Companies

  • 4.1. Traditional Glucose Meters Companies - Pipeline Products by Stage of Development
  • 4.2. Traditional Glucose Meters - Pipeline Products by Stage of Development

5. Traditional Glucose Meters Companies and Product Overview

  • 5.1. 4a Medicom GmbH Company Overview
    • 5.1.1. 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Ascensia Diabetes Care Holdings AG Company Overview
    • 5.2.1. Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Biopeak Corporation Company Overview
    • 5.3.1. Biopeak Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. BlueVine Graphene Industries, Inc. Company Overview
    • 5.4.1. BlueVine Graphene Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Elte Sensoric GmbH Company Overview
    • 5.5.1. Elte Sensoric GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Glucosat Company Overview
    • 5.6.1. Glucosat Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. GlucoStats System Pte Ltd. Company Overview
    • 5.7.1. GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Grove Instruments Inc. (Inactive) Company Overview
    • 5.8.1. Grove Instruments Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. IntelliDx Inc Company Overview
    • 5.9.1. IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. LabStyle Innovations Corp. Company Overview
    • 5.10.1. LabStyle Innovations Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. LifeScan, Inc. Company Overview
    • 5.11.1. LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. LighTouch Medical, Inc. Company Overview
    • 5.12.1. LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Massachusetts Institute of Technology Company Overview
    • 5.13.1. Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NIR Diagnostics Inc. (Inactive) Company Overview
    • 5.14.1. NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. OrSense Ltd. Company Overview
    • 5.15.1. OrSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Pepex Biomedical, Inc. Company Overview
    • 5.16.1. Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. RSP Systems A/S Company Overview
    • 5.17.1. RSP Systems A/S Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Sensys Medical, Inc. Company Overview
    • 5.18.1. Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Sentec Pte Ltd Company Overview
    • 5.19.1. Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Socrates Health Solutions, Inc. Company Overview
    • 5.20.1. Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Spire Corporation Company Overview
    • 5.21.1. Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. TecMed, Inc. Company Overview
    • 5.22.1. TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. University of Central Florida Company Overview
    • 5.23.1. University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Florida Company Overview
    • 5.24.1. University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Worcester Polytechnic Institute Company Overview
    • 5.25.1. Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview

6. Traditional Glucose Meters- Recent Developments

  • 6.1. Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016
  • 6.2. Jul 11, 2016: LabStyle Innovations Joins College Diabetes Network (CDN)
  • 6.3. Jul 08, 2016: RSP Systems Raises USD5 Million in Series A Financing
  • 6.4. Jun 21, 2016: PositiveID's Mobile Lab Business Completed 80 Projects in the First Half of 2016
  • 6.5. May 31, 2016: PositiveID Adds Benedikt von Braunmuhl to its Board of Advisors
  • 6.6. May 26, 2016: PositiveID to Present at the 2016 Marcum MicroCap Conference on June 1st
  • 6.7. May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015
  • 6.8. May 11, 2016: LabStyle Innovations Reports Q1 2016 Results
  • 6.9. May 05, 2016: LabStyle Innovations Granted Key Patent in Europe Relating to the Dario Diabetes Management Tool
  • 6.10. Apr 26, 2016: Intuity Medical Receives FDA Clearance to Market POGO Automatic Blood Glucose Monitoring System
  • 6.11. Mar 15, 2016: LabStyle Innovations' Dario Blood Glucose Monitoring System online e-store and membership program live in USA
  • 6.12. Mar 09, 2016: LabStyle Innovations Granted U.S. Patent Expanding IP for Fluids Testing into Industrial Applications via Mobile Devices and Apps
  • 6.13. Jan 26, 2016: LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016
  • 6.14. Dec 22, 2015: LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
  • 6.15. Dec 16, 2015: Dario Diabetes Management Solution Garners Global Media Coverage
  • 6.16. Dec 01, 2015: Sysmex Establishes New Subsidiary in Ghana - Reinforcing the Company's Business Foundation in the Markets of West and Central Africa
  • 6.17. Nov 11, 2015: LabStyle Innovations Enters into Distribution Agreement with Centaur Pharma
  • 6.18. Oct 29, 2015: LabStyle Innovations Reports Dario Blood Glucose Monitor Demonstrates Over 99% Accuracy in New Study
  • 6.19. Oct 23, 2015: Studies Presented at Diabetes Technology Meeting Demonstrate the Accuracy of ARKRAY Blood Glucose Meters and Test Strips
  • 6.20. Oct 15, 2015: LabStyle Innovations to Report New Data at Diabetes Technology Meeting On October 22 and 23, 2015.
  • 6.21. Oct 12, 2015: LabStyle Innovations to Present New Case Study at 5th EAI International Conference on Wireless Mobile Communication and Healthcare in London on October 15, 2015
  • 6.22. Sep 30, 2015: LabStyle Innovations to Present at Health 2.0's 9th Annual Fall Conference in Silicon Valley on October 7, 2015
  • 6.23. Sep 15, 2015: Sysmex to Expand U.S. Reagent Factory - Aiming to Meet Growing Demand in the Americas
  • 6.24. Sep 09, 2015: LabStyle Innovations Receives Granted Patent in the U.S. Expanding its IP to Address Management of Chronic Diseases Through Smart Phones
  • 6.25. Aug 25, 2015: LabStyle Innovations to Exhibit at Australian Diabetes Society's Annual Meeting on August 26 - 28, 2015

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Traditional Glucose Meters - Pipeline Products by Stage of Development
  • Table 2: Traditional Glucose Meters - Pipeline Products by Territory
  • Table 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path
  • Table 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date
  • Table 5: Traditional Glucose Meters - Ongoing Clinical Trials
  • Table 6: Traditional Glucose Meters Companies - Pipeline Products by Stage of Development
  • Table 7: Traditional Glucose Meters - Pipeline Products by Stage of Development
  • Table 8: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: GlucoPEARL - Product Status
  • Table 10: GlucoPEARL - Product Description
  • Table 11: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Next Generation Blood Glucose Monitoring System - Product Status
  • Table 13: Next Generation Blood Glucose Monitoring System - Product Description
  • Table 14: Biopeak Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Non-Invasive Glucose Analyzer - Product Status
  • Table 16: Non-Invasive Glucose Analyzer - Product Description
  • Table 17: BlueVine Graphene Industries, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Minimally Invasive Glucose Monitoring Device - Product Status
  • Table 19: Minimally Invasive Glucose Monitoring Device - Product Description
  • Table 20: Elte Sensoric GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Infrared Laser Glucometer - Product Status
  • Table 22: Infrared Laser Glucometer - Product Description
  • Table 23: Portable Infrared Laser Glucometer - Product Status
  • Table 24: Portable Infrared Laser Glucometer - Product Description
  • Table 25: Glucosat Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Glucosat - Product Status
  • Table 27: Glucosat - Product Description
  • Table 28: GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: First Generation Glucose Monitoring Device - Product Status
  • Table 30: First Generation Glucose Monitoring Device - Product Description
  • Table 31: Grove Instruments Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Grove Glucometer - Product Status
  • Table 33: Grove Glucometer - Product Description
  • Table 34: Non-Invasive Diabetes And Pre-Diabetes Screener - Product Status
  • Table 35: Non-Invasive Diabetes And Pre-Diabetes Screener - Product Description
  • Table 36: IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Optimus - Product Status
  • Table 38: Optimus - Product Description
  • Table 39: LabStyle Innovations Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Dario - Product Status
  • Table 41: Dario - Product Description
  • Table 42: Next Generation Dario Blood Glucose Monitoring Device - Product Status
  • Table 43: Next Generation Dario Blood Glucose Monitoring Device - Product Description
  • Table 44: LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: OneTouch Verio Blood Glucose System - Version 3 - Product Status
  • Table 46: OneTouch Verio Blood Glucose System - Version 3 - Product Description
  • Table 47: LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: LighTouch Glucose Monitor - Product Status
  • Table 49: LighTouch Glucose Monitor - Product Description
  • Table 50: LighTouch Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 51: LighTouch Glucose Monitor - In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds
  • Table 52: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Non-Invasive Blood Glucose Monitor - Product Status
  • Table 54: Non-Invasive Blood Glucose Monitor - Product Description
  • Table 55: NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: GlucoNIR - Product Status
  • Table 57: GlucoNIR - Product Description
  • Table 58: OrSense Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Second Generation Monitor - Product Status
  • Table 60: Second Generation Monitor - Product Description
  • Table 61: Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Trio Total Glucose Meter - Product Status
  • Table 63: Trio Total Glucose Meter - Product Description
  • Table 64: RSP Systems A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: 3rd Generation GlucoBeam - Product Status
  • Table 66: 3rd Generation GlucoBeam - Product Description
  • Table 67: Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Sensys GTS - Product Status
  • Table 69: Sensys GTS - Product Description
  • Table 70: Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: NoStrip Blood Glucose Meter - Product Status
  • Table 72: NoStrip Blood Glucose Meter - Product Description
  • Table 73: Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Socrates Companion - Product Status
  • Table 75: Socrates Companion - Product Description
  • Table 76: Spire Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Non-Invasive Glucose Monitor - Product Status
  • Table 78: Non-Invasive Glucose Monitor - Product Description
  • Table 79: TecMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: GlucoCheck Critical Care Monitor - Product Status
  • Table 81: GlucoCheck Critical Care Monitor - Product Description
  • Table 82: Surgical Suite Unit - Product Status
  • Table 83: Surgical Suite Unit - Product Description
  • Table 84: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Non-Invasive Glucose Monitoring System - Product Status
  • Table 86: Non-Invasive Glucose Monitoring System - Product Description
  • Table 87: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Diabetic UF Sensor - Product Status
  • Table 89: Diabetic UF Sensor - Product Description
  • Table 90: Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Non-invasive Glucose Measuring Device - Product Status
  • Table 92: Non-invasive Glucose Measuring Device - Product Description
  • Table 93: Glossary

List of Figures

  • Figure 1: Traditional Glucose Meters - Pipeline Products by Stage of Development
  • Figure 2: Traditional Glucose Meters - Pipeline Products by Territory
  • Figure 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path
  • Figure 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date
  • Figure 5: Traditional Glucose Meters - Ongoing Clinical Trials
Back to Top